Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") ...

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

Discover how the brain "eats" itself during a marathon, and how the recovery process opens doors to possible MS treatments.

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...